Stay updated on Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.

Latest updates to the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedUpdated the site revision label from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check25 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check54 days agoChange DetectedRevision: v3.4.2 was added and the prior government funding notice (Revision: v3.4.1) was removed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check61 days agoChange DetectedA global notice about a lapse in government funding and NIH operations was added. The site revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check68 days agoChange DetectedGlossary display added and a QC status line updated to 'Last Update Submitted that Met QC Criteria'; the page revision note now shows v3.4.0 (replacing v3.3.4). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Switch for Metastatic Renal Cell Carcinoma Clinical Trial page.